These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3043023)

  • 1. Growth factor production by Creutzfeldt-Jakob disease cell lines.
    Oleszak EL; Murdoch G; Manuelidis L; Manuelidis EE
    J Virol; 1988 Sep; 62(9):3103-8. PubMed ID: 3043023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent.
    Manuelidis EE; Fritch WW; Kim JH; Manuelidis L
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):871-5. PubMed ID: 3543937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.
    Bockman JM; Kingsbury DT
    J Virol; 1988 Sep; 62(9):3120-7. PubMed ID: 2900341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants.
    Bendheim PE; Bockman JM; McKinley MP; Kingsbury DT; Prusiner SB
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):997-1001. PubMed ID: 2579394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial activation varies in different models of Creutzfeldt-Jakob disease.
    Baker CA; Lu ZY; Zaitsev I; Manuelidis L
    J Virol; 1999 Jun; 73(6):5089-97. PubMed ID: 10233972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prions--infectious pathogens causing the spongiform encephalopathies.
    Prusiner SB; Kingsbury DT
    CRC Crit Rev Clin Neurobiol; 1985; 1(3):181-200. PubMed ID: 3915974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.
    Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1993; 130(3-4):301-16. PubMed ID: 8517790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential retroviral RNAs in Creutzfeldt-Jakob disease.
    Murdoch GH; Sklaviadis T; Manuelidis EE; Manuelidis L
    J Virol; 1990 Apr; 64(4):1477-86. PubMed ID: 2108258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.
    Akowitz A; Sklaviadis T; Manuelidis L
    Nucleic Acids Res; 1994 Mar; 22(6):1101-7. PubMed ID: 8152913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity and host responses in Creutzfeldt-Jakob disease.
    Manuelidis L; Fritch W
    Virology; 1996 Feb; 216(1):46-59. PubMed ID: 8615006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice.
    Kordek R; Nerurkar VR; Liberski PP; Isaacson S; Yanagihara R; Gajdusek DC
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9754-8. PubMed ID: 8790403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal interference between specific CJD and scrapie agents in neural cell cultures.
    Nishida N; Katamine S; Manuelidis L
    Science; 2005 Oct; 310(5747):493-6. PubMed ID: 16239476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease.
    Manuelidis EE
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):1-17. PubMed ID: 3880808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between astrocytes and oligodendroglia in human and experimental Creutzfeldt-Jakob disease and scrapie.
    Liberski PP; Brown P; Cervenakova L; Gajdusek DC
    Exp Neurol; 1997 Mar; 144(1):227-34. PubMed ID: 9126175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.
    Sklaviadis T; Dreyer R; Manuelidis L
    Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ultrastructural diversity of scrapie-associated fibrils isolated from experimental scrapie and Creutzfeldt-Jakob disease.
    Liberski PP; Brown P; Xiao SY; Gajdusek DC
    J Comp Pathol; 1991 Nov; 105(4):377-86. PubMed ID: 1770176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants.
    Manuelidis L; Valley S; Manuelidis EE
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4263-7. PubMed ID: 2408277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrapie-associated fibrils in Creutzfeldt-Jakob disease.
    Merz PA; Somerville RA; Wisniewski HM; Manuelidis L; Manuelidis EE
    Nature; 1983 Dec 1-7; 306(5942):474-6. PubMed ID: 6358899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.